PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Department of Microbiology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.\', \'Institute for Global Health (ISGlobal), Barcelona, Spain.\', \'Department of Pharmacy, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Medical Intensive Care Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Department of Internal Medicine, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Department of International Health, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.\', \'Computer System Unit, Hospital Clinic, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jac/dkab321
?:hasPublicationType
?:journal
  • The Journal of antimicrobial chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34473275
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all